BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 26676497)

  • 1. Diagnosis of latent Mycobacterium tuberculosis infection: tuberculin test versus interferon-gamma release.
    Ferreira TF; Matsuoka Pda F; Santos AM; Caldas Ade J
    Rev Soc Bras Med Trop; 2015; 48(6):724-30. PubMed ID: 26676497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
    BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The performance of quantiferon-TB gold in-tube (QFT-IT) test compared to tuberculin skin test (TST) in detecting latent tuberculosis infection (LTBI) in the presence of HIV coinfection in a high TB-burden area with BCG-vaccinated population.
    James PM; Ganaie FA; Kadahalli RL
    J Int Assoc Provid AIDS Care; 2014; 13(1):47-55. PubMed ID: 23482341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients.
    Yilmaz N; Zehra Aydin S; Inanc N; Karakurt S; Direskeneli H; Yavuz S
    Lupus; 2012 Apr; 21(5):491-5. PubMed ID: 22140142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of concordance and costs between tuberculin skin test and QuantiFERON(®)-TB Gold In-Tube in the diagnosis of latent tuberculosis infection among contacts of patients with pulmonary tuberculosis].
    Martinez Lacasa X; Canals Font R; Jaen Manzanera A; Cuchi Burgos E; Lite Lite J
    Med Clin (Barc); 2015 Nov; 145(10):427-32. PubMed ID: 25794770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Snapshot of Quantiferon TB gold testing in Northern Mexico.
    González-Salazar F; Vargas-Villarreal J; Garcialuna-Martínez FJ; Rivera G; Moreno-Treviño MG; Montfort-Gardeazabal JM; Garcialuna-Martínez E
    Tuberculosis (Edinb); 2011 Dec; 91 Suppl 1():S34-7. PubMed ID: 22099419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
    Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
    Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
    Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
    Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of QuantiFERON(®)-TB Gold In-Tube in tuberculosis contact investigation: experience in a tuberculosis unit.
    Gonzślez-Moreno J; García-Gasalla M; Gállego-Lezaun C; Fernández-Baca V; Mir Viladrich I; Cifuentes-Luna C; Serrano Bujalance A; Salom Vallespir A; Payeras Cifre A
    Infect Dis (Lond); 2015 Apr; 47(4):244-51. PubMed ID: 25692351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
    Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
    Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the QuantiFERON®-TB Gold In-Tube Assay and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in an Iranian Referral Hospital.
    Pourakbari B; Yousefi K; Mahmoudi S; Sadeghi RH; Mamishi S
    Infect Disord Drug Targets; 2019; 19(2):141-144. PubMed ID: 29493468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of IGRA tests and TST in the diagnosis of latent tuberculosis infection and predicting tuberculosis in risk groups in Krakow, Poland.
    Kruczak K; Duplaga M; Sanak M; Cmiel A; Mastalerz L; Sladek K; Nizankowska-Mogilnicka E
    Scand J Infect Dis; 2014 Sep; 46(9):649-55. PubMed ID: 25073535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculin test versus interferon gamma release assay in pregnant women with household contacts of tuberculosis patients.
    Chalid MT; Puspawaty D; Tahir AM; Najdah H; Massi MN
    Int J Mycobacteriol; 2022; 11(4):364-370. PubMed ID: 36510919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.
    Hsia EC; Schluger N; Cush JJ; Chaisson RE; Matteson EL; Xu S; Beutler A; Doyle MK; Hsu B; Rahman MU
    Arthritis Rheum; 2012 Jul; 64(7):2068-77. PubMed ID: 22238071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
    Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
    Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of interferon-γ release assays (IGRAs) to the diagnosis of latent tuberculosis infection after renal transplantation.
    Hadaya K; Bridevaux PO; Roux-Lombard P; Delort A; Saudan P; Martin PY; Janssens JP
    Transplantation; 2013 Jun; 95(12):1485-90. PubMed ID: 23694948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for latent tuberculosis infection in patients with chronic inflammatory arthritis: discrepancies between tuberculin skin test and interferon-γ release assay results.
    Costantino F; de Carvalho Bittencourt M; Rat AC; Loeuille D; Dintinger H; Béné MC; Faure G; Chary-Valckenaere I
    J Rheumatol; 2013 Dec; 40(12):1986-93. PubMed ID: 24085550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon gamma release assays: principles and practice.
    Lalvani A; Pareek M
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):245-52. PubMed ID: 19783328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
    So H; Yuen CS; Yip RM
    Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The assessment of cytokines in Quantiferon supernatants for the diagnosis of latent TB infection in a tribal population of Melghat, India.
    Bapat PR; Husain AA; Daginawala HF; Agrawal NP; Panchbhai MS; Satav AR; Taori GM; Kashyap RS
    J Infect Public Health; 2015; 8(4):329-40. PubMed ID: 25824629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.